Immunic eyes Phase 3 after MS disability gains in Phase 2 CALLIPER trial

By Proactive Investors / May 07, 2025 / www.youtube.com / Article Link


Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt talked with Proactive's Stephen Gunnion about the latest results from the ...

Recent News

Big Gold has another strong quarter, but some signs growth cooling
May 12, 2025 / www.canadianminingreport.com

Gold stocks nearly regain highs on rising metal price
May 12, 2025 / www.canadianminingreport.com

Gold stocks down as risk on move continues
May 05, 2025 / www.canadianminingreport.com

Mixed outlook for resources on new Canadian government
May 05, 2025 / www.canadianminingreport.com

Gold's Bull Market Pullbacks
April 28, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok